Adicet Bio Inc (ACET) Stock Forecast & Price Target
Adicet Bio Inc · NASDAQ
$8.14+0.35 (+4.49%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Adicet Bio Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $18.00 to $100.00 (about 5.6x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $41.00 sits 404% above the current $8.14. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-1.51 next quarter toward $-3.49 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Adicet Bio Inc.
As of Jul, 4 of 4 firms rate ACET a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ACET EPS & revenue forecast
EPS · NEXT QUARTER
$-1.51
Range $-2.37 – $-0.58 · 4 analysts · -67% YoY
Next period, 4 analysts expect Adicet Bio Inc to earn $-1.51 a share (range $-2.37 – $-0.58), versus $-4.64 a year earlier. Full-year consensus is $-8.80, growing to $-3.49 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 4 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $42.8M next year.
Top analysts covering Adicet Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ACET.
#1
Yatin Suneja
Guggenheim · Rank #28
Buy
$100.00+1128.5% to target
Overall win rate
52%
+ Follow
#2
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Buy
$27.00+231.7% to target
Overall win rate
38%
+ Follow
#3
EW
Edward White
HC Wainwright & Co. · Rank #241
Hold
No targeton ACET
Overall win rate
31%
+ Follow
#4
Reni J. Benjamin
JMP Securities · Rank #290
Hold
No targeton ACET
Overall win rate
33%
+ Follow
#5
Robert Driscoll
Wedbush · Rank #313
Buy
$5.00-38.6% to target
Overall win rate
30%
+ Follow
ACET stock forecast FAQ
What is ACET's average 12-month price target?+
The 4 analysts with a live target average $41.00 for Adicet Bio Inc over the next 12 months, ranging from a $100.00 high to a $18.00 low.
Is ACET stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ACET?+
The Street-high target is $100.00 (Guggenheim), and the Street-low is $18.00 (Canaccord Genuity). The average of all 4 active targets is $41.00.
How many Wall Street analysts cover ACET?+
4 analysts have an active rating on Adicet Bio Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering ACET?+
Among analysts who currently cover ACET, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #28). Their current call is Buy with a $100.00 target.
What is Adicet Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-1.51 per share (range $-2.37 – $-0.58) across 4 analysts. Full-year EPS is projected at $-8.80, rising to $-3.49 the following year.
How much revenue is Adicet Bio Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $42.8M next year.
Have analysts been upgrading or downgrading ACET lately?+
As of Jul, 4 of 4 firms rate ACET a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ACET calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
